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1 |  INTRODUCTION
Autism spectrum disorder (ASD) is characterized by impair-
ments in ordinary social communication, along with restricted 
and stereotyped behaviors and interests. The morbidity rate 
remains under 1% of the population with onset before the age 
of 3 years. In recent years, advances in genomic techniques 
have provided novel insight into the genetic causes of ASD,1 
including mutations in the autism susceptibility candidate 2 
(AUTS2) gene.
AUTS2 is a well‐conserved gene in vertebrates, compris-
ing 19 exons located on chromosome 7q11.22. The frequency 
of AUTS2 mutation is 1/2000.2,3 Its 19 exons are divided into 
two parts: the first six exons at the 5′ end, which are separated 
by large introns, and the remaining 13 exons at the 3′ end, 
which are compact with smaller clustered introns.4 In addi-
tion to ASD, variants in AUTS2 have been demonstrated to 
be associated with other neurodevelopmental disorders such 
as schizophrenia and developmental delay,1 along with physi-
cal malformations such as dysmorphic features, short stature, 
and microcephaly.2
We encountered a patient with ASD and a heterozygous 
AUTS2 mutation that was defined as likely pathogenic in 
ClinVar (GenomeDx, RCV000657843.1). However, the phe-
notype of this mutation has never been reported.
Here, we report the clinical details of a patient with this 
mutation. To our knowledge, this is the first case of an AUTS2 
variant associated with cleft lip and palate.
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Abstract
We report a patient with autism and cleft lip and palate carrying a de novo heterozy-
gous AUTS2 mutation, c.1464_1467del ACTC (p.Tyr488*). Although the causal re-
lationship between cleft lip and palate and this mutation is unclear, this case report 
may expand the clinical phenotype of AUTS2 syndrome.
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2 |  CASE REPORT
The 8‐year‐old patient was the first child born to nonconsan-
guineous, healthy Japanese parents. The family history was 
unremarkable. The boy was born at 36 weeks of gestation by 
vaginal delivery and did not suffer asphyxia. His birth weight 
was 2005 g (−2.5 SD), with a height of 44.2 cm (−2.3 SD), 
and head circumference of 26.5 cm (−4.8 SD). He exhibited 
dysmorphic features, including highly arched eyebrows, mi-
crognathia (Figure 1A), cleft lip and palate, microcephaly, 
left cryptorchidism, right inguinal hernia, and a ventricular 
septal defect that was closed at 10 months of age. The cleft 
lip and palate were treated surgically at 10 and 19 months 
of age, respectively. His motor and intellectual develop-
ments were delayed from early childhood; he walked alone 
at 23 months old and spoke a single word at 35 months old. 
He required tube feeding from the age of 4 months owing to 
feeding difficulties. Brain magnetic resonance imaging and 
electroencephalogram revealed no abnormalities. Various 
blood tests, including amino acid analysis, lactate, and pyru-
vate, were normal. Chromosomal analysis and array compar-
ative genomic hybridization showed no abnormalities.
At 3 years of age, the patient exhibited marked hyperac-
tivity, impulsivity, and acoustic hyperesthesia. His face was 
always expressionless, and he could not make eye contact. He 
showed developmental language delay, and the diagnosis of 
ASD was finally made. Medications were needed to control 
his remarkable hyperactivity, such as risperidone, atomoxe-
tine, and aripiprazole. Oral food intake gradually increased, 
and nasogastric tube feeding was not required by the age of 
3 years and 9 months; however, his feeding difficulties con-
tinued until almost 5 years of age. He was still small in terms 
of physical status at 5 years and 10 months: weight 10.9 kg 
(−2.9 SD), height 94.6 cm (−3.7 SD), and head circumfer-
ence 43.0 cm (−4.4 SD). He is currently enrolled in special 
support education classes.
A trio exome analysis was performed as described pre-
viously.5 The research protocol was approved by the local 
institutional ethical review board of the University of 
Tsukuba and Keio University School of Medicine following 
the Ethical Guidelines for Human Genome/Gene Analysis 
Research of the Ministry of Health, Labor and Welfare of 
Japan and the Declaration of Helsinki Principles. Informed 
consent was obtained from the parents. Genomic DNA was 
extracted from peripheral blood leukocytes of the patient and 
both parents, and whole‐exome sequencing was performed 
using the SureSelect XT Human All Exon V6 (Agilent 
Technologies) and HiSeq 2500 (Illumina) platforms. Whole‐
exome sequencing revealed a mutation in autism suscepti-
bility candidate 2 (AUTS2), NM_015570.3:c.1464_1467del 
ACTC (p.Tyr488*), which was determined to be a de novo 
mutation in the patient (Figure 1B). These sequence data 
have been reported to ClinVar by GenomeDx under acces-
sion number RCV000657843.1. This variant is located in 
exon 8, at the C‐terminus of AUTS2 and is predicted to dis-
rupt mRNA translation.
3 |  DISCUSSION
The main functions of AUTS2 involve neuronal migration, 
extension, and branching of the neurites and construction of 
the correct neuronal network.4 Previous studies have indi-
cated that mutations in AUTS2 are associated with not only 
neurodevelopmental disorders such as ASDs, attention defi-
cit hyperactivity disorder, and intellectual disability but also 
short stature, microcephaly, feeding difficulties, dysmorphic 
features, and other malformations.7-9 Beunders et al2 coined 
the term "AUTS2 syndrome" to describe these various symp-
toms and established a scoring system composed of four 
grades: 0‐7, 8‐12, 13‐18, and 19‐31. Patients with deletions 
at the N‐terminus typically show only neurodevelopment dis-
orders, whereas those with deletions at the C‐terminus ex-
hibit neurodevelopment disorders as well as other physical 
features and feeding difficulties.1,2 Mutations in the C‐termi-
nus of AUTS2 appear to cause more severe phenotypes. Our 
F I G U R E  1  Characteristics of the 
patient carrying a mutation in exon 8 of 
AUTS2. A, Proband at the age of 8 y. 
These photographs show the highly arched 
eyebrows, broad nasal bridge, microcephaly, 
retrognathia, low‐set ears, narrow mouth, 
and short length of the fifth fingers but no 
skeletal anomaly. B, Sanger sequencing 
was performed, and a de novo mutation, 
c.1464_1467del ACTC (p.Tyr 488*), in 
AUTS2 was identified in the proband
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T A B L E  1  Features of the AUTS2 syndrome depending on region of the deletion2
Cases Our case Beunders' cases    
Exon deleted 8 1 to 5 6 to 19 (c terminal) all
Number of the patients 1 7 10 2
Growth and feeding
Low birth weight + 1/7 14% 4/10 40% 1/2 50%
Short stature <p10a + 1/7 14% 9/10 90% 1/2 50%
Microcephaly <p2b + 3/7 43% 8/10 80% 1/2 50%
Feeding difficulties + 1/7 14% 6/10 60% 1/2 50%
Neurodevelopmental disorders
Intellectual disability + 6/7 86% 10/10 100% 1/2 50%
Autism/autistic behavior + 2/7 29% 3/10 30% 0/2 0%
Sound sensitivity + 0/7 0% 0/10/ 0% 2/2 100%
Hyperactivity/ADHD + 0/7 0% 2/10 20% 1/2 50%
Other − 1/7 14% 2/10 20% 0/2 0%
Neurological disorders
General hypotonia − 1/7 14% 4/10 40% 1/2 50%
Structural brain anomaly − 1/7 14% 2/10 20% 0/2 0%
Cerebral palsy/spasticity − 1/7 14% 6/10 60% 2/2 100%
Other − 1/7 14% 2/10 20% 0/2 0%
Dysmorphic feature
Highly arched eyebrows + 1/7 14% 6/10 60% 0/2 0%
Hypertelorism − 0/7 0% 7/10 70% 1/2 50%
Proptosis − 1/7 14% 5/10 50% 0/2 0%
Short palpebral fissures − 2/7 29% 3/10 30% 1/2 50%
Up slanting palpebral fissures − 0/7 0% 1/10 10% 1/2 50%
Ptosis − 2/7 29% 5/10 50% 0/2 0%
Epicanthal fold − 1/7 14% 5/10 50% 0/2 0%
Strabismus − 2/7 29% 3/10 30% 0/2 0%
Prominent nasal tip − 0/7 0% 4/10 40% 0/2 0%
Anteverted nares − 0/7 0% 2/10 20% 0/2 0%
Deep/broad nasal bridge + 1/7 14% 3/10 30% 2/2 100%
Short/upturned philtrum − 2/7 29% 4/10 40% 1/2 50%
Micro/retrognathia + 1/7 14% 5/10 50% 1/2 50%
Low‐set ears + 0/7 0% 5/10 50% 0/2 0%
Ear pit − 0/7 0% 2/10 20% 0/2 0%
Narrow mouth + 3/7 43% 6/10 60% 1/2 50%
Other + 1/7 14% 5/10 50% 2/2 100%
Skeletal disorders
Kyphosis/scoliosis − 0/7 0% 2/10 20% 0/2 0%
Arthrogryposis/shallow palmar creases − 0/7 0% 2/10 20% 0/2 0%
Tight heel cords − 0/7 0% 2/10 20% 2/2 100%
Other − 1/7 14% 3/10 30% 1/2 50%
Congenital malformations
Hernia umbilicalis/inguinalis + 0/7 0% 2/10 20% 0/2 0%
Patent foreman ovale/atrial septum defect − 1/7 14% 1/10 10% 1/2 50%
(Continues)
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patient has a deletion in exon 8 of AUTS2, which is located 
in the C‐terminus, and he presents a severe phenotype con-
sistent with these previous descriptions. Indeed, the patient's 
AUTS2 syndrome score was 16/31, which is classified as the 
second most severe grade2 (Table 1).
Considering the biological function of AUTS2 in the 
brain, researchers found that nuclear AUTS2 combines with 
the promoter/enhancers of various genes related to brain de-
velopment.4,10 Gao et al11 showed that the most important 
amino acids to recruit P300, which is a well‐known histone 
acetyltransferase known to play a role in craniofacial devel-
opment, may be located at positions 404‐717.11 These posi-
tions correspond to the region between exon 7 and exon 16.2 
The de novo mutation identified in our patient creates a stop 
codon at amino acid 488 in exon 8. This mutation may cause 
nonsense‐mediated decay and loss of the entire cDNA or re-
sult in loss of the region needed for recruiting P300. Many 
distant‐acting enhancers for craniofacial development are 
also associated with P300.
The main unique features of our AUTS2 syndrome pa-
tient are the cleft lip and palate. The prevalence of cleft lip 
and palate is approximately 1.7 per 1000 live births in Asia, 
which also has the highest average occurrence rate for cleft 
lip and palate worldwide. In Japanese populations, the prev-
alence of cleft lip and palate is 2.06 per 1000 live births and 
shows a significant male bias.6 The definite cause of cleft lip 
and palate remains largely unknown.6 There are many known 
risk factors, including maternal smoking, alcohol consump-
tion, medications, nutrition, and genetic factors. Our patient 
did not have any of these risk factors for cleft lip and palate 
except for ethnic group and sex.
Since this is the only reported case of cleft palate asso-
ciated with AUTS2 mutation, a causal relationship warrants 
further investigation. Moreover, further studies should focus 
on the broader functions of AUTS2 beyond its role in the ner-
vous system to explain why a variant of this gene would cause 
physical malformations, including cleft lip and palate.
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